Vimian Group AB (publ) (OTCMKTS:VIMGF) Short Interest Down 16.4% in December

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totalling 65,900 shares, a decline of 16.4% from the November 30th total of 78,800 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Vimian Group AB (publ) Price Performance

Shares of OTCMKTS VIMGF opened at C$3.89 on Tuesday. The business has a 50-day moving average price of C$3.63 and a 200 day moving average price of C$3.44. Vimian Group AB has a 52-week low of C$2.68 and a 52-week high of C$4.12.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.